Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
J. Taylor Crandall currently holds 2,137 shares of Accretive Health, Inc. (AH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Taylor Crandall has been a net seller of AH stock. They have purchased $0 and sold $27.7M worth of shares.
J. Taylor Crandall's most recent insider trade was on Jul 23, 2026, when they sold 1,180 shares at $38.14 per share.
J. Taylor Crandall serves as Executive at Accretive Health, Inc. (AH). They have executed 32 insider transactions totaling $27.7M over their tenure at the company.
J. Taylor Crandall holds the position of Executive at Accretive Health, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 23 years and currently hold a stake valued at $0.
J. Taylor Crandall has shown a selling trading pattern, with $0 in total purchases and $27.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by J. Taylor Crandall was on Mar 30, 2011, when they sold $18.3M worth of AH shares. This transaction involved 814,110 shares at $22.44 per share.
J. Taylor Crandall currently owns 2,137 shares of Accretive Health, Inc. (AH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of J. Taylor Crandall's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. J. Taylor Crandall has 32 Form 4 filings on record as an insider at Accretive Health, Inc..
Set alerts for J. Taylor Crandall and 40,000+ other insiders.